Hyaluronic acid in the treatment of cancer
作者： Nigel C. Phillips , Mario C. Filion
DOI:
关键词: Cancer 、 Materials science 、 Biochemistry 、 Hyaluronic acid
摘要: The present invention relates to a composition and method comprising purified HA, second anti-neoplastic agent pharmaceutically acceptable carrier, wherein the HA are administered mammal having cancer in an amount effective treat cancer.
google.co.in参考文章(57)
Graham A. W. Rook, John L. Stanford, Immuno-therapeutic composition of killed cells from mycobacterium vaccae ,(1985)
John L. Cantrell, Vaccine containing tumor antigens and adjuvants ,(1987)
Gerhard Pulverer, Methods of increasing tolerance to radiotherapy and chemotherapy using propioni bacteria ,(1985)
Edgar E. Ribi, John L. Cantrell, Steven M. Schwartzman, Stable composition and preparation thereof ,(1984)
Stanley J. Alkemade, Thomas C. Buckley, Graeme McRae, Immunostimulatory bacterial cell wall traction ,(1994)
Alfred E Fox, Benjamin S Schwartz, Frank J Turner, Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof ,(1962)
Gerard Ayme, New immunostimulant medicament and process of preparing same ,(1977)
Nigel C. Phillips, Mario C. Filion, Composition and method for the treatment of bladder cancer ,(1998)
Edgar Lederer, Arlette Adam, Frank M. Berger, Jean-Francois Petit, Louis Chedid, Process for preparing vaccine adjuvant ,(1972)
Edgar Lederer, Rita Ciorbaru, Arlette Adam, Frank Berger, Jean-Francois Petit, Louis Chedid, Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction ,(1973)